Atheric™ Pharmaceutical LLC is focused on rapid development and commercialization of re-purposed drugs to prevent and treat Zika, Yellow fever, other viral diseases and bio-threats. Atheric's lead drug products are reformulated broad spectrum antiviral drugs that inhibit autophagy-dependent viral replication as well as other anti-viral pathways, and which may include preventing infection by mosquito-transmitted viruses . Atheric is committed to providing broad-spectrum antiviral medical countermeasures.
How Effective Does an Anti-Arbovirus Drug Need to Be?
Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, explains how effective a drug needs to be to generate protection.
Which Licensed Compounds Can Be Used Against Zika?
Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses which existing licensed drug compounds are able to be repurposed for use against Zika.